FEATURED ARTICLES
First-In-Human Porcine Kidney Transplant Trial Builds On Expanded Access Success
eGenesis CEO Mike Curtis discusses the first-in-human trial of EGEN-2784, which they're studying whether a porcine kidney can restore near-normal quality of life while awaiting a human transplant.
-
Lessons Learned While Taking Glioblastoma Drug From Bench To Clinic
MimiVax CEO Mike Ciesielski recounts the company's transition from academia to industry, hitting on topics like vendor partnerships, FDA conversations, and manufacturer selection.
-
Considerations For Allergic Rhinitis Trials Are Nothing To Sneeze At
Inimmune CEO David Burkhart explains how a GSK layoff led to the formation of a new company focused on treating allergic rhinitis. Here, he shares success from the company's approach to site selection, trial design, and timing.
-
With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout
Crystallis President and CEO James Mackay shares insights from the company’s clinical decision-making for dotinurad, including the inclusion of an open label extension.